[go: up one dir, main page]

PT1238086E - Vacina para aumentar as respostas imunes a vacina contra virus herpes simples - Google Patents

Vacina para aumentar as respostas imunes a vacina contra virus herpes simples

Info

Publication number
PT1238086E
PT1238086E PT00983967T PT00983967T PT1238086E PT 1238086 E PT1238086 E PT 1238086E PT 00983967 T PT00983967 T PT 00983967T PT 00983967 T PT00983967 T PT 00983967T PT 1238086 E PT1238086 E PT 1238086E
Authority
PT
Portugal
Prior art keywords
vaccine
type
hsv
nucleic acid
protein
Prior art date
Application number
PT00983967T
Other languages
English (en)
Inventor
Eric M Mishkin
Robert J Natuk
Michael W Pride
Maninder K Sidhu
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PT1238086E publication Critical patent/PT1238086E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55538—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT00983967T 1999-12-17 2000-12-07 Vacina para aumentar as respostas imunes a vacina contra virus herpes simples PT1238086E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17231399P 1999-12-17 1999-12-17

Publications (1)

Publication Number Publication Date
PT1238086E true PT1238086E (pt) 2006-07-31

Family

ID=22627181

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00983967T PT1238086E (pt) 1999-12-17 2000-12-07 Vacina para aumentar as respostas imunes a vacina contra virus herpes simples

Country Status (16)

Country Link
EP (1) EP1238086B1 (pt)
JP (1) JP2003517042A (pt)
KR (1) KR100773390B1 (pt)
CN (1) CN1222619C (pt)
AT (1) ATE319833T1 (pt)
AU (1) AU783730B2 (pt)
BR (1) BR0016419A (pt)
CA (1) CA2406678A1 (pt)
CY (1) CY1105604T1 (pt)
DE (1) DE60026588T2 (pt)
DK (1) DK1238086T3 (pt)
ES (1) ES2258987T3 (pt)
IL (1) IL149810A0 (pt)
MX (1) MXPA02005867A (pt)
PT (1) PT1238086E (pt)
WO (1) WO2001044477A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI315986B (en) * 2002-11-07 2009-10-21 Synergy America Inc Compositions and methods for treating or preventing pneumococcal infection
ES2732815T3 (es) 2009-05-22 2019-11-26 Genocea Biosciences Inc Vacunas frente al virus del herpes simple de tipo 2: composiciones y métodos para provocar una respuesta inmunitaria
KR101008582B1 (ko) * 2010-09-20 2011-01-17 (주)칠칠공사 달비계용 2중 안전 샤클조립체
CA2856697A1 (en) 2010-11-24 2012-06-07 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
JP6199878B2 (ja) * 2011-11-23 2017-09-20 ジェノセア バイオサイエンシーズ， インコーポレイテッド 単純ヘルペスウイルス２型に対する核酸ワクチン：免疫応答を誘発する組成物及び方法
ES2847930T3 (es) 2013-01-07 2021-08-04 Mucosal Vaccine Tech Llc Vacunas terapéuticas para el tratamiento de las infecciones por el virus del herpes simple de tipo 2
CA2942166A1 (en) 2014-03-03 2015-09-11 Albert Einstein College Of Medicine, Inc. Recombinant herpes simplex virus 2 (hsv-2) vaccine vectors
US10918712B2 (en) 2014-03-03 2021-02-16 Albert Einstein College Of Medicine Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
CN104721839A (zh) * 2015-03-17 2015-06-24 浙江省医学科学院 一种预防单纯疱疹病毒ii型的疫苗
CN104830781A (zh) * 2015-05-05 2015-08-12 杨光华 基于hsv-2抗原的dc细胞、靶向性免疫细胞群及其制备方法和用途
US10350288B2 (en) 2016-09-28 2019-07-16 Genocea Biosciences, Inc. Methods and compositions for treating herpes
CN111051333B (zh) * 2017-08-30 2024-04-05 Km生物医薬股份公司 修饰型HSV gD蛋白及包含其的疫苗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1053017E (pt) * 1998-02-12 2004-12-31 Wyeth Corp Vacinas compreendendo interleucina-12 e antigenio de virus herpes simplex

Also Published As

Publication number Publication date
WO2001044477A1 (en) 2001-06-21
BR0016419A (pt) 2002-08-20
KR20020073348A (ko) 2002-09-23
EP1238086B1 (en) 2006-03-08
CN1222619C (zh) 2005-10-12
ATE319833T1 (de) 2006-03-15
JP2003517042A (ja) 2003-05-20
CN1434864A (zh) 2003-08-06
AU2065101A (en) 2001-06-25
IL149810A0 (en) 2002-11-10
ES2258987T3 (es) 2006-09-16
KR100773390B1 (ko) 2007-11-09
CA2406678A1 (en) 2001-06-21
MXPA02005867A (es) 2002-10-23
EP1238086A1 (en) 2002-09-11
DE60026588T2 (de) 2007-01-18
DE60026588D1 (de) 2006-05-04
DK1238086T3 (da) 2006-06-26
AU783730B2 (en) 2005-12-01
CY1105604T1 (el) 2010-07-28

Similar Documents

Publication Publication Date Title
CY1105604T1 (el) Μεθοδος ενισχυσης ανοσων απαντησεων στο εμβολιο κατα του ιου του απλου ερπητα
DK0587780T4 (da) Smitstof, som forårsager Mystery Swine Disease,vaccinepræparater og diagnostiske sæt
ATE350057T1 (de) Impfstoffzusammesetzung
EP1847549A3 (en) Papillomavirus polyprotein constructs
WO2002061113A3 (en) Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation
DE69637642D1 (de) Und kombinierte zusammensetzungen und deren verwendung
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
WO2000020027A3 (en) Methods for therapeutic vaccination
EP1326633A4 (en) COMPOSITION WITH IMMUNOGENIC MICROPARTICLES
DK0957935T3 (da) Chlamydia-vacciner og immunogene præparater indeholdende et ydre membran-antigen samt fremgangsmåde til fremstilling deraf
ZA936629B (en) Potentiation of immunogenic response
BR0014138A (pt) Uso de um vetor adenoviral deficiente em replicação, e, métodos para reforçar, e para induzir resposta imune de célula cd8+ t a um antìgeno em um indivìduo
ECSP024257A (es) Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas
BR9710849A (pt) Vacina contendo uma peróxi-redoxina e/ou uma beta-tubulina.
AU8467201A (en) Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
BR0013574A (pt) Antìgeno vacina de moraxella
BR0112486A (pt) Poliproteìna, molécula de ácido nucleico, plasmìdeo, vacina recombinante ou vacina atenuada, composição farmacêutica, e, método para imunizar um indivìduo contra hiv
DE69933237D1 (de) Multikomponentimpfstoff mit mindestens zwei antigenen von haemophilus influenzae
ATE374622T1 (de) Genetische impstoffe mit adjuvans
BR9905780A (pt) Antìgenos vacinais de leptospira para prevenção da laptospirose
EP1502602A3 (en) Methods for therapeutic vaccination
DK0524421T3 (da) Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse
BR0009746A (pt) Molécula de veìculo, composição imunogênica, polipeptìdeo, método para tratar um indivìduo, e, plasmìdeos pebl1-pv e pviii
BR0213554A (pt) Timosina para aumento da imunização genética